tert-butyl 4-{4-[(methylamino)methyl]pyrid-2-yl}piperazine-1-carboxylate; 97%; 5g; F.W.: 306.40; C16H26N4O2; M.P.: 62.5-63.5; Primary CAS: 946409-15-0
-
P/N:
CC50646DE
- UOM: EA
- UOM Qty: 1
|
|
tert-butyl 4-{4-[(methylamino)methyl]pyrid-2-yl}piperazine-1-carboxylate; 97%; 1g; F.W.: 306.40; C16H26N4O2; M.P.: 62.5-63.5; Primary CAS: 946409-15-0
-
P/N:
CC50646DA
- UOM: EA
- UOM Qty: 1
|
|
pentafluorophenyl 2-[4-(tert-butoxycarbonyl)piperazin-1-yl]isonicotinate; 90%; 5g; F.W.: 473.39; C21H20F5N3O4; M.P.: 112-113; Primary CAS: 944450-81-1
-
P/N:
CC50626DE
- UOM: EA
- UOM Qty: 1
|
|
pentafluorophenyl 2-[4-(tert-butoxycarbonyl)piperazin-1-yl]isonicotinate; 90%; 1g; F.W.: 473.39; C21H20F5N3O4; M.P.: 112-113; Primary CAS: 944450-81-1
-
P/N:
CC50626DA
- UOM: EA
- UOM Qty: 1
|
|
n-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)benzylamine; 95%; 1g; F.W.: 203.24; C11H13N3O; Primary CAS: 921938-59-2
-
P/N:
CC49546DA
- UOM: EA
- UOM Qty: 1
|
|
n-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)benzylamine; 95%; 250mg; F.W.: 203.24; C11H13N3O; Primary CAS: 921938-59-2
-
P/N:
CC49546CB
- UOM: EA
- UOM Qty: 1
|
|
3-(3-methyl-1,2,4-oxadiazol-5-yl)benzaldehyde; 97%; 1g; F.W.: 188.18; C10H8N2O2; M.P.: 105-109; Primary CAS: 273727-50-7
-
P/N:
CC49504DA
- UOM: EA
- UOM Qty: 1
|
|
3-(3-methyl-1,2,4-oxadiazol-5-yl)benzaldehyde; 97%; 250mg; F.W.: 188.18; C10H8N2O2; M.P.: 105-109; Primary CAS: 273727-50-7
-
P/N:
CC49504CB
- UOM: EA
- UOM Qty: 1
|
|
4-Piperidin-1-ylbenzonitrile; 97%; 25g; F.W.: 186.26; M.P.: 51-53deg.C; Primary CAS: 1204-85-9
-
P/N:
CC33916EB
- UOM: EA
- UOM Qty: 1
|
|
4-Piperidin-1-ylbenzonitrile; 97%; 10g; F.W.: 186.26; M.P.: 51-53deg.C; Primary CAS: 1204-85-9
-
P/N:
CC33916EA
- UOM: EA
- UOM Qty: 1
|
|
